Discover
Stocks
Consumer Goods
CTKB
CTKB
Cytek Biosciences Inc
7.20
-0.05
(
-0.70%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
CTKB
Cytek Biosciences Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Cytek Biosciences Inc's revenues increased by 28.20% and amounted to 164.04M. Net income increased by 9,453.85% to 2.48M. Net assets decreased by NaN to 427.82M and EPS decreased from N/A to 0.02.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment